Inova Research Studies: Active/Enrolling - Inova Health System
Inova Research Studies: Active/Enrolling - Inova Health System
Inova Research Studies: Active/Enrolling - Inova Health System
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Program -<br />
Principal Investigator<br />
Study Title<br />
Contact<br />
Principal Investigator<br />
Study Title<br />
Contact<br />
Principal Investigator<br />
Study Title<br />
Contact<br />
Principal Investigator<br />
Study Title<br />
Contact<br />
Principal Investigator<br />
Study Title<br />
Contact<br />
Interventional Cardiology<br />
Raybuck, Bryan MD<br />
A phase III, double-blind, randomized placebo-controlled study, to evaluate the effects of<br />
dalcetrapib on cardiovascular (CV) risk in stable CHD patients, with a documented recent<br />
Acute Coronary Syndrome (ACS)<br />
Sally Keyte, RN, IHVI Cardiology <strong>Research</strong>, 703-776-2995, sally.keyte@inova.org<br />
Raybuck, Bryan MD<br />
JOMED JOSTENT Coronary Stent Graft, HDE Number H000001<br />
Jessica Wolfe, RN, IHVI Cardiology <strong>Research</strong>, 703-776-3567, jessica.wolfe@inova.org<br />
Thompson, James MD<br />
PREMIUM<br />
Sally Keyte, RN, IHVI Cardiology <strong>Research</strong>, 703-776-2995, sally.keyte@inova.org<br />
Thompson, James MD<br />
Closure of Atrial Septal Defects with the AMPLATZER Septal Occluder Post Approval<br />
Study (ASD PMS II)<br />
Sally Keyte, RN, IHVI Cardiology <strong>Research</strong>, 703-776-2995, sally.keyte@inova.org<br />
Thompson, James MD<br />
PFO ACCESS Registry<br />
Sally Keyte, RN, IHVI Cardiology <strong>Research</strong>, 703-776-2995, sally.keyte@inova.org<br />
1/18/2010 Page 40 of 64
Change language